Application of sodium valproate to preparation of medicine for restraining formation of glial scars and medical composition for restraining formation of glial scars
A technology of sodium valproate and glial scar, applied in the direction of drug combination, anhydride/acid/halide active ingredients, blood diseases, etc., to achieve the effect of inhibiting activation, inhibiting the formation of glial scar, and promoting recovery
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Protective effect of VPA on focal ischemic stroke in rats.
[0049] Male SD rats were randomly divided into a control group (sham operation group), a control administration group (VPA 250 mg / kg), a model group, and a model administration group (VPA 250 mg / kg), with 10 rats in each group. The rat model of transient middle cerebral artery occlusion (tMCAO) was established by suture method. After 90 minutes of MCAO, the rats in the control administration group and the model administration group were injected with VPA solution (250 mg / kg) intraperitoneally immediately, and the rats in the model group and the sham operation group were reperfused with a corresponding volume of normal saline immediately. After the first injection of VPA and normal saline, the second injection was completed at the same time the next day, and then once a day for a total of 28 days. The neurological symptoms of rats after reperfusion were scored by the Longa method once a week for four weeks. Th...
Embodiment 2
[0061] Inhibitory effect of VPA on the expression of glial scar-associated proteins GFAP, Neurocan and Phosphacan in ischemic rats.
[0062] Male SD rats were randomly divided into a control group (sham operation group), a control administration group (VPA 250mg / kg), a model group, and a model administration group (VPA 250mg / kg), with 3 rats in each group. The rat model of transient middle cerebral artery occlusion (tMCAO) was established by suture method. After 90 minutes of MCAO, the rats in the control administration group and the model administration group were injected with VPA solution (250 mg / kg) intraperitoneally immediately, and the rats in the model group and the sham operation group were reperfused with a corresponding volume of normal saline immediately. After the first injection of VPA and normal saline, the second injection was completed at the same time the next day, and then once a day for a total of 7 days. The brains were decapitated, and the expressions of ...
Embodiment 3
[0065] Inhibitory effect of VPA on the expression of related proteins GFAP, Neurocan and Phosphacan in an in vitro glial scar model.
[0066] When the primary astrocytes were cultured to a certain extent in a culture dish or a 24-well plate (accounting for about 80% of the holes in the culture dish or culture plate), they were divided into a control group (non-OGD) and a control administration group ( non-OGD+VPA), glial scar model group (OGD6h-Re24h) and model administration group (OGD6h-Re24h+VPA), the glial scar-associated proteins GFAP, Neurocan and Phosphacan were detected by western blot method or immunofluorescence method Express.
[0067] Figure 5 It is a schematic diagram of the effect of VPA on the expression of related proteins GFAP, Neurocan and Phosphacan in the in vitro glial scar model in Example 3, mean±SD, n=3, compared with the control group ##p<0.01; compared with the model group, * *p<0.01.
[0068] Figure 6 It is the immunofluorescence pattern of VPA...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com